Sigma Verdict
Key takeaways
- Revenue for the quarter reported Nov 12, 2026 was $10.41B. That is 1.06% above consensus of $10.30B and 53.07% above $6.80B a year earlier.
- Sigma's revenue estimate of $10.46B had an error of 0.45%, against 1.05% for consensus. EPS was $4.16, compared with consensus of $4.06 and Sigma's $4.26.
- Guidance for next quarter is $10.6B–$11.6B, with a midpoint of $11.1B, 0.82% above consensus. The company exceeded the top of its range in 0 of its last 8 quarters.
- For the Feb 11, 2027 report, Sigma estimates revenue of $11.18B, 1.51% above consensus of $11.01B. Sigma estimates EPS of $4.48, against consensus of $4.30.
- The stance is Constructive with Medium conviction. The Sigma Score (71) and Sigma Value (81.76) support it, and 4 of 5 rule inputs were available.
Executive summary
What happened. Applied Materials reported revenue of $10.41B on Nov 12, 2026, 1.06% above consensus of $10.30B and up 53.07% from $6.80B a year earlier. EPS was $4.16, 2.46% above consensus of $4.06. Sigma's estimates were closer than consensus on both lines. The revenue error was 0.45% against 1.05%, and the EPS error was 2.28% against 2.40%.
What we expect now. For the quarter to be reported on Feb 11, 2027, Sigma estimates revenue of $11.18B, within a band of $11.06B–$11.42B, and 1.51% above consensus of $11.01B. Sigma's EPS estimate of $4.48 is 4.11% above consensus of $4.30. The revenue estimate sits within company guidance of $10.6B–$11.6B. In our view, the track record is still short: only 1 live quarter has settled for this company.
What the market prices. The shares trade at $380.95, a forward P/E of 20.22 and a trailing P/E of 29.97, with a market value of $302.3B. Forward EPS growth is 31.97%, and the free cash flow yield is 1.86%. Our reading is that the gap between trailing and forward P/E reflects the earnings growth the market expects. The Sigma Value factor of 81.76 rates the stock as cheap relative to its own fundamentals.
Our stance. The published rule gives a Constructive stance with Medium conviction, on a total of 2 points from 4 of 5 inputs. The Sigma Score of 71 and the Sigma Value of 81.76 each add one point. Guidance in line with consensus (+0.8%) and a last revenue surprise close to consensus (+1.1%) add none. The 90-day consensus revision is not available yet, because our consensus history is shorter than 90 days.
The quarter: Sigma vs. Street vs. actual
| Reported Nov 12, 2026 | Sigma (locked) | Consensus | Actual | Closer |
|---|---|---|---|---|
| Revenue | $10.46B | $10.30B | $10.41B | Sigma |
| EPS | $4.26 | $4.06 | $4.16 | Sigma |
Revenue: reported quarters and the next Sigma estimate
Our forecast vs. consensus
| Next report (expected Feb 11, 2027) | Sigma | Consensus | Gap | Sigma range |
|---|---|---|---|---|
| Revenue | $11.18B | $11.01B | +1.5% | $11.06B–$11.42B |
| EPS | $4.477 | $4.30 | +4.1% | — |
Valuation
| Share price at publication | $380.95 |
| Forward P/E (next twelve months) | 20.2× |
| Trailing P/E | 30.0× |
| Consensus EPS growth (next fiscal year vs. this one) | 32.0% |
| Free-cash-flow yield | 1.9% |
| Gross / operating margin | 50.0% / 32.2% |
| Sigma Value factor (higher = cheaper) | 82 / 100 |
Thesis, catalysts and risks
Growth with consistent delivery: revenue rose 53.07% year on year to $10.41B. Revenue beat consensus by 2.95% on May 14, 2026, by 1.33% on Aug 13, 2026 and by 1.06% on Nov 12, 2026.
High business quality: the Sigma Quality factor is 97.02, the gross margin is 49.99% and the operating margin is 32.19%.
Valuation support: the Sigma Value factor is 81.76, and the forward P/E is 20.22 against forward EPS growth of 31.97%.
Feb 11, 2027: next quarterly report. Sigma estimates revenue of $11.18B against consensus of $11.01B and guidance of $10.6B–$11.6B.
Guidance for the following quarter in the Feb 11, 2027 release, compared with consensus at that time.
The 90-day consensus revision input becomes available once our consensus history reaches 90 days.
Product and pricing cycles are not captured by the estimate. This includes memory price turns and competitors' capacity additions, as well as macro and currency effects.
Beats have narrowed recently, from 2.95% to 1.33% to 1.06%. The company exceeded the top of its guidance range in 0 of its last 8 quarters, which limits upside beyond $11.6B.
Sigma Momentum is 40.14 and the free cash flow yield is 1.86%. Sigma's company record rests on only 1 settled live quarter, so its accuracy edge is not yet established.
We would view the case as weaker if revenue reported on Feb 11, 2027 falls below consensus of $11.01B, or if the Sigma Score drops below 70. The same applies if the Sigma Value factor falls below 60.
Methodology
What our estimate is
Our statistical estimate starts from analyst consensus and adjusts it by how far Applied Materials, Inc. has typically beaten consensus over its last eight quarters, weighting recent quarters more and pulling back toward consensus when the beats have narrowed. Company guidance is reported, not used as a cap: the estimate is within the company’s guidance range; Applied Materials, Inc. has exceeded the top of its range in 0 of its last 8 quarters.
How the stance is set (stance-rule-v2)
| Input | Value | What it means | +1 at | −1 at | Points |
|---|---|---|---|---|---|
| Company guidance (next quarter, midpoint) vs. consensus | +0.8% | guidance is in line with consensus (+0.8%) | ≥ 1% | ≤ -1% | 0 |
| Consensus revision over 90 days (next quarter revenue) | n/a | not available yet: our consensus history is shorter than 90 days | ≥ 2% | ≤ -2% | — |
| Last quarter: reported revenue vs. consensus | +1.1% | revenue was close to consensus (+1.1%) | ≥ 2% | < 0% | 0 |
| Sigma Score (0–100) | 71 | strong overall quality and valuation score | ≥ 70 | ≤ 40 | +1 |
| Sigma Value factor (0–100, higher = cheaper) | 82 | cheap relative to its own fundamentals | ≥ 60 | ≤ 30 | +1 |
What this does not capture
- Product and pricing cycles, including memory price turns and competitors’ capacity additions.
- Macro and currency effects.
- One-off items such as restructuring, legal or tax charges.
- Changes in management or strategy.
The stance is a quarter-level signal, not a valuation.
Our record on this company
1 live quarter settled for AMAT: Sigma error 0.45% vs. consensus 1.05%. Track record